Citation Impact
Citing Papers
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma
1999
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Current strategies of chemotherapy in osteosarcoma
2006
Chemotherapy resistance in osteosarcoma: current challenges and future directions
2006
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma
2011
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Chronic Myeloproliferative Disorders
2003
Survival of children with bone sarcoma in Europe since 1978
2001
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
PET as a potential tool for imaging molecular mechanisms of oncology in man
2001
Cancer to bone: a fatal attraction
2011 Standout
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
2007
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Prosthetic-Joint Infections
2004 Standout
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
2011
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity
2001
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
2003
Osteosarcoma treatment: state of the art
2009
Common Musculoskeletal Tumors of Childhood and Adolescence
2012
Clinico-histologic parameters of osteosarcoma patients with late relapse
2006
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII
2003
Osteosarcoma
2010 Standout
Osteosarcoma in very young children
2010
Frontline treatment of localized osteosarcoma without methotrexate
2011
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
2005
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
2001
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Pulmonary dirofilariasis in a Caucasian patient with metastasised osteosarcoma in a non-endemic European region
2010
Primary bone osteosarcoma in the pediatric age: State of the art
2006
Chemotherapy for Osteosarcoma without High-Dose Methotrexate: A 12-Year Follow-Up on 53 Patients
2007
MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone
2014
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
2011
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Therapy for Osteosarcoma
2008
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
2001
Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up
2010
Neoadjuvant chemotherapy for osteosarcoma of the extremity
2001
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Functional imaging and the orthopaedic surgeon
2002
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors
2013
Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children
2009
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Second Malignant Neoplasm in Patients With Osteosarcoma of the Extremities Treated With Adjuvant and Neoadjuvant Chemotherapy
2006
Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
2007
Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis
2010
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
2009
Management of osteosarcoma
2006
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
2003
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy
2006
Controversies in the Management of Oropharynx Cancer
2008
Etiology and Pathogenesis of Osteochondrosis
2007 Standout
The Epidemiology of Osteosarcoma
2009 Standout
Head and Neck Cancer
2020 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study
2000
Combined Modality Treatment for Osteosarcoma Occurring as a Second Malignant Disease
1999
Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report
2000
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
High-Activity Samarium-153-EDTMP Therapy in Unresectable Osteosarcoma
1999
Osteochondritis Dissecans
2021
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
2003
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma
2004
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
2006
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
2010
Natural product and natural product derived drugs in clinical trials
2014 Standout
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases
2006
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
2005
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2003
Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups
2005
Osteosarcoma of the spine
2002
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651
2003
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Mathias Werner being referenced
Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group
2010
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Giant cell tumour of bone: morphological, biological and histogenetical aspects
2006
Osteosarcoma: The COSS Experience
2009
Dose‐reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
2002
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
2010
Aktuelles zur Histogenese des Riesenzelltumors
2002
P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
1997
Osteochondritis Dissecans: Etiology, Pathology, and Imaging with a Special Focus on the Knee Joint
2017
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
1999